Rethinking Gleason pattern quantification in predicting metastasis: results of 20 years of follow‐up in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
Histopathology · 2026
DOI: 10.1111/his.70052 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Histopathology, 2026. Verfasst von Lisa J Kroon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Neoplasm Grading. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jaap Schouten Foundation.
Abstract (Originalsprache)
Introduction
The Gleason grading system for prostate cancer (PCa) is based on the proportions of Gleason patterns (GP) 3–5. While pure GP3 has minimal metastatic potential, it is unclear whether GP3 quantity in the presence of GP4 and GP5 affects oncological outcomes.
Objective
To assess the predictive value of PCa biopsy GP lengths on long‐term metastasis‐free survival (MFS).
Methods
Prostate biopsies of 1,881 men with screen‐detected PCa who participated in the Dutch part of the European Randomized Study of Screening for Prostate Cancer (ERSPC) between 1993 and 2007 were revised for GP 3–5 length. Multivariable Cox regression analyses were used to evaluate the relationship between GP lengths and MFS truncated at 20 years, adjusting for clinical‐tumour stage (cT), prostate‐specific antigen (PSA), percentage positive biopsies and the presence of invasive cribriform/intraductal carcinoma (CR/IDC). Results and limitations On multivariable analysis, ≥cT2, PSA, percentage positive cores and absolute length of GP4 and GP5 were all significantly associated with MFS. The discriminative ability was improved by adding CR/IDC to the model. Total GP3 length was neither associated with MFS in the model with (hazard ratio [HR] 0.99, 95% confidence interval [CI] 0.97–1.00, P = 0.3) nor without CR/IDC (HR 0.98, 95% CI 0.96–1.01, P = 0.2). A limitation is the lack of targeted biopsies. Conclusion and clinical implications GP3 length does not have an impact on the prediction of MFS in biopsies, once GP4/GP5 lengths are known. Although GP3 percentage is essential in Gleason grading, MFS is related to absolute GP4 and GP5 quantity rather than their proportion to GP3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
- Department of Urology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
- Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands.
ORCID-Profile: Lisa J Kroon, Sebastiaan Remmers, Ivo I de Vos, Charlotte F Kweldam, L Lucia Rijstenberg, Roderick C N van den Bergh, Monique J Roobol, Geert J L H van Leenders
Förderung
- Jaap Schouten Foundation
Zitieren
APA
Kroon, L. J., Remmers, S., de Vos, I. I., Kweldam, C. F., Rijstenberg, L. L., van den Bergh, R. C. N., Roobol, M. J., & van Leenders, G. J. L. H. (2026). Rethinking Gleason pattern quantification in predicting metastasis: results of 20 years of follow‐up in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Histopathology. https://doi.org/10.1111/his.70052
Vancouver
Kroon LJ, Remmers S, de Vos II, Kweldam CF, Rijstenberg LL, van den Bergh RCN, et al. Rethinking Gleason pattern quantification in predicting metastasis: results of 20 years of follow‐up in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Histopathology. 2026. doi:10.1111/his.70052
BibTeX
@article{Kroon2026,
author = {Kroon, Lisa J and Remmers, Sebastiaan and de Vos, Ivo I and Kweldam, Charlotte F and Rijstenberg, L Lucia and van den Bergh, Roderick C N and Roobol, Monique J and van Leenders, Geert J L H},
title = {Rethinking Gleason pattern quantification in predicting metastasis: results of 20 years of follow‐up in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer},
journal = {Histopathology},
year = {2026},
doi = {10.1111/his.70052}
}
EUVIMED